BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 44 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,889 | +22.4% | 2,500,000 | 0.0% | 0.01% | +20.0% |
| Q2 2023 | $1,543 | -3.0% | 2,500,000 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $1,591 | +65.0% | 2,500,000 | 0.0% | 0.01% | +100.0% |
| Q4 2022 | $964 | -99.9% | 2,500,000 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $1,116,000 | +11.3% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,003,000 | -17.6% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,217,000 | – | 2,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diameter Capital Partners LP | 43,287,000 | $27,670,133 | 4.63% |
| Affinity Asset Advisors, LLC | 11,000,000 | $7,120,872 | 2.35% |
| INHERENT GROUP, LP | 31,250,000 | $20,000,750 | 2.27% |
| Context Capital Management, LLC | 26,583 | $17,209 | 1.44% |
| BRAIDWELL LP | 42,294,000 | $27,379,090 | 0.90% |
| DeepCurrents Investment Group LLC | 35,355,000 | $22,459,155 | 0.88% |
| ARISTEIA CAPITAL, L.L.C. | 45,280,000 | $29,312,082 | 0.69% |
| Aequim Alternative Investments LP | 31,000,000 | $20,067,912 | 0.64% |
| Saltoro Capital, LP | 1,600,000 | $979,200 | 0.61% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 5,000,000 | $3,130,846 | 0.46% |